EMERGE: A randomized phase II study of the antibody-drug conjugate glembatumumab vedotin in advanced glycoprotein NMB - Expressing breast cancer

Denise A. Yardley, Robert Weaver, Michelle E. Melisko, Mansoor N. Saleh, Francis P. Arena, Andres Forero, Tessa Cigler, Alison Stopeck, Dennis Citrin, Ira Oliff, Rebecca Bechhold, Randa Loutfi, Agustin A. Garcia, Scott Cruickshank, Elizabeth Crowley, Jennifer Green, Thomas Hawthorne, Michael J. Yellin, Thomas A. Davis, Linda T. Vahdat

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'EMERGE: A randomized phase II study of the antibody-drug conjugate glembatumumab vedotin in advanced glycoprotein NMB - Expressing breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences